Genistein reverses free fatty acid-induced insulin resistance in HepG2 hepatocytes through targeting JNK

Abstract

This study investigated the effects and molecular mechanisms of genistein in improving insulin resistance induced by free fatty acids (FFAs) in HepG2 hepatocytes. A model of insulin resistance in HepG2 cells was established by adding palmitic acid (0.5 mmol/L) to the culture medium and the cells were treated by genistein. Glucose consumption of HepG2 cells was determined by glucose oxidase method. The levels of c-jun N-terminal kinase (JNK) phosphorylation, insulin receptor substrate-1 (IRS-1) Ser307 phosphorylation, JNK, IRS-1, phosphatidylinositol-3-kinase p85 (PI-3K p85) and glucose transporter 1 (GLUT1) proteins were detected by Western blotting. The results showed that after the treatment with palmitic acid for 24 h, the insulin-stimulated glucose transport in HepG2 cells was inhibited, and the glucose consumption was substantially reduced. Meanwhile, the expressions of IRS-1, PI-3K p85 protein and GLUT1 were obviously reduced, while the levels of JNK phosphorylation and IRS-1 Ser307 phosphorylation and the expression of JNK protein were significantly increased, as compared with cells of normal control. However, the aforementioned indices, which indicated the existence of insulin resistance, were reversed by genistein at 1–4 μmol/L in a dose-dependent manner. It was concluded that insulin resistance induced by FFAs in HepG2 hepatocytes could be improved by genistein. Genistein might reverse FFAs-induced insulin resistance in HepG2 cells by targeting JNK.

Keywords

Genistein / insulin resistance / c-jun N-terminal kinase / free fatty acids

References

[1] HsuC.S., ChiuW.C., YehS.L.. Effects of soy isoflavone supplementation on plasma glucose, lipids, and antioxidant enzyme activities in streptozotocin-induced diabetic rats. Nutr Res, 2003, 23: 67-75

[2] ChiuT.M., HuangC.C., LinT.J., et al.. In vitro and in vivo anti-photoaging effects of an isoflavone extract from soybean cake. Ethnopharmacol, 2009, 26(1): 108-113

[3] ChoiJ.S., SongJ.. Effect of genistein on insulin resistance, renal lipid metabolism, and anti-oxidative activities in ovariectomized rats. Nutrition, 2009, 25(6): 676-685

[4] AzadbakhtL., KimiagarM., MehrabiY., et al.. Soy inclusion in the diet improves features of the metabolic syndrome: a randomized crossover study in postmenopausal women. Am J Clin Nutr, 2007, 85(3): 735-741

[5] JayacopalV., AlbertazziP., KilpatrickE.S., et al.. beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care, 2002, 25(10): 1709-1714

[6] CederrothC.R., VinciguerraM., GjinovciA., et al.. Dietary phytoestrogens activate AMP activated protein kinase with improvement in lipid and glucose metabolism. Diabetes, 2008, 57(5): 1176-1185

[7] KimS., ShinH.J., KimS.Y., et al.. Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARalpha. Mol Cell Endocrinol, 2004, 220(1): 51-58

[8] DangZ.C., AudinotV., PapapoulosS.E., et al.. Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein. J Biol Chem, 2003, 278(2): 962-967

[9] ShenP., LiuM.H., NgT.Y., et al.. Differential effects of isoflavones, from Astragalus membranaceus and Pueraria thomsonii, on the activation of PPARalpha, PPARgamma, and adipocyte differentiation in vitro. J Nutr, 2006, 136(4): 899-905

[10] Diaz DelfinJ., MoralesM., CaellesC.. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor by inhibition of the c-Jun NH2-terminal kinase pathway. Diabetes, 2007, 56(7): 1865-1871

[11] FrittittaL., SbracciaP., CostanzoB.V., et al.. High insulin levels do not influence PC-1 gene expression and protein content in human muscle tissue and hepatoma cells. Diabetes Metab Res Rev, 2000, 16(1): 26-32

[12] ChenQ., XiaY.P., QiuZ.Y.. Effect of ecdysterone on glucose metabolism in vitro. Life Sciences, 2006, 78(10): 1108-1113

[13] LeeJ.S.. Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, and lipid profile in streptozotocin-induced diabetic rats. Life Sciences, 2006, 79(16): 1578-1584

[14] SoneeM., SumT., WangC., et al.. The Soy isoflavone, genistein, protects human cortical neuronal cells from oxidative stress. Neurotoxicology, 2004, 25(5): 885-891

[15] WaetzigV., LooseK., HaeusgenW., et al.. c-Jun N-terminal kinases mediate Fas-induced neurite regeneration in PC12 cells. Biochem Pharmacol, 2008, 76(11): 1476-1484

[16] LehnertM., ReljaB., Sun-Young LeeV., et al.. A peptide inhibitor of C-jun N-terminal kinase modulates hepatic damage and the inflammatory response after hemorrhagic shock and resuscitation. Shock, 2008, 30(2): 159-165

[17] ReljaB., SchwestkaB., LeeV.S., et al.. Inhibition of c-Jun N-terminal Kinase after hemorrhage but before resuscitation mitigates hepatic damage and the inflammatory response in female rats. Shock, 2009, 32(5): 509-516

[18] KaraskovE., ScottC., ZhangL., et al.. Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis. Endocrinol, 2006, 147(7): 3398-3407

[19] NelsonB.A., RobinsonnK.A., BuseM.G.. High glucose and glucosamine induced resistance via different mechanisms in 3T3-L1 adipocytes. Diabetes, 2000, 49(6): 981-991

[20] YinJ., HuR., ChenM., et al.. Effects of berberine on glucose metabolism in vitro. Metabolism, 2002, 51(11): 1439-1441

[21] ChoiM.S., JungU.J., YeoJ., et al.. Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice. Diabetes Metab Res Rev, 2008, 24(1): 74-81

[22] Ae ParkS., ChoiM.S., ChoS.Y., et al.. Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice. Life Sciences, 2006, 79(12): 1207-1213

[23] DandonaP., AljadaA., BandyopadhyayA.. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol, 2004, 25(1): 4-7

[24] JiroH., tuncmanG., ChangL., et al.. A central role for JNK in obesity and insulin resistance. Nature, 2002, 420(6913): 333-336

[25] RaghebR., ShanabG.M., MedhatA.M., et al.. Free fatty acid-induced muscle insulin resistance and glucose uptake dysfunction: Evidence for PKC activation and oxidative stress-activated signaling pathways. Biochem Biophy Res Commun, 2009, 389(2): 211-216

[26] UngerR.H.. Lipid overload and overflow: metabolic trauma and the metabolic syndrome. Trends Endocrinol Metab, 2003, 14(9): 398-403

[27] De LucaC., OlefskyJ.M.. Stressed out about obesity and insulin resistance. Nat Med, 2006, 12(1): 41-42

[28] LeeM.S., KimC.H., HoangD.M., et al.. Genistein-derivatives from tetracera scandens stimulate glucose-uptake in L6 myotubes. Biol Pharm Bull, 2009, 32(3): 504-508

[29] Von HertzenL., ForsblomC., StumpeK., et al.. Highly elevated serum phytoestrogen concentrations in patients with diabetic nephropathy. J Intern Med, 2004, 255(5): 602-609

[30] NakajimaM., CooneyM.J., TuA.H., et al.. Normalization of retinal vascular permeability experimental diabetes with genistein. Invest Ophthalmol Vis Sci, 2001, 42(9): 2110-2114

[31] PalanisamyN., ViswanathanP., AnuradhanC.V.. Effect of Genistein, a soy isoflavone, on whole body insulin sensitivity and renal damage induced by a high-fructose diet. Ren Fail, 2008, 30(6): 645-654

[32] AguirreV., WernerE.D., GiraudJ., et al.. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem, 2002, 277(2): 1531-1537

[33] AguirreV., UchidaT., YenushL., et al.. The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307. J Biol Chem, 2000, 275(12): 9047-9054